Rothschild Investment LLC’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17K Buy
380
+279
+276% +$1.21K ﹤0.01% 2724
2026
Q1
$391 Buy
101
+65
+181% +$267 ﹤0.01% 3190
2025
Q4
$150 Buy
+36
New +$139 ﹤0.01% 3155
2025
Q3
Sell
-165
Closed -$234 3221
2025
Q2
$234 Buy
+165
New +$234 ﹤0.01% 2909

Other funds holding PGEN

Rothschild Investment LLC's PGEN Position: Q2 2026 in Review

Rothschild Investment LLC increased its Precigen (PGEN) stake by 276% in Q2 2026, buying an estimated $1.21K and bringing the position to 380 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #2724.

Rothschild Investment LLC first reported a position in PGEN in Q2 2025 and has held it in 4 quarters since. 74 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Rothschild Investment LLC held 380 shares of Precigen worth $2.17K as of Q2 2026.
  • Rothschild Investment LLC bought 279 Precigen shares in Q2 2026, an estimated $1.21K.
  • Precigen made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2724 holding.
  • Rothschild Investment LLC first reported a position in Precigen in Q2 2025 and has held it in 4 quarters since.
  • 74 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.